GlucoTrack EBITDA 2011-2025 | GCTK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GlucoTrack ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GlucoTrack ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$230.9B
Boston Scientific (BSX)	$156.3B
Stryker (SYK)	$149.6B
EssilorLuxottica (ESLOY)	$141.3B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$44B
ResMed (RMD)	$40.2B
Agilent Technologies (A)	$35.7B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.6B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.9B
Zimmer Biomet Holdings (ZBH)	$21B
Smith & Nephew SNATS (SNN)	$16.4B
Baxter (BAX)	$12.7B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$8.1B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.2B
Haemonetics (HAE)	$2.6B
Acuren (TIC)	$2.3B
Curaleaf Holdings (CURLF)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B